Adequan is an FDA-approved PSGAG (polysulfated glycosaminoglycan) injection for intramuscular use in horses. For the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints.
Adequan is proven to:
Reduce the swelling and inflammation associated with joint disease to improve lameness
Restore synovial lubrication that facilitates movement and reduces local inflammation
Repair cartilage and rapidly aid in the production of new cartilage
Reverse the disease process that leads the loss of cartilage components by inhibiting harmful enzymes that attack cartilage and synovial fluid